Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
42,894
Total Claims
$2.9M
Drug Cost
2,263
Beneficiaries
$1,285
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 2,621 Pain Management providers
+40%
Opioid rate vs peers
57.6% vs 41.3% avg
+222%
Cost per patient vs peers
$1,285 vs $399 avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
57.6%
Opioid Rate
24,727
Opioid Claims
$1.6M
Opioid Cost
14.0%
Long-Acting Rate
This provider's opioid prescribing rate of 57.6% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 0 claims · $0
Generic: 40,720 claims · $1.3M
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Myristate | 636 | $400K |
| Methylnaltrexone Bromide | 144 | $358K |
| Oxycodone Hcl/Acetaminophen | 6,617 | $272K |
| Hydrocodone/Acetaminophen | 9,128 | $255K |
| Oxycodone Hcl | 226 | $142K |
| Gabapentin | 8,188 | $127K |
| Naloxegol Oxalate | 250 | $115K |
| Pregabalin | 1,614 | $88K |
| Buprenorphine Hcl | 126 | $84K |
| Oxycodone Hcl | 2,569 | $81K |
| Diclofenac Sodium | 1,152 | $80K |
| Buprenorphine Hcl/Naloxone Hcl | 1,035 | $72K |
| Hydrocodone Bitartrate | 70 | $48K |
| Morphine Sulfate | 1,381 | $46K |
| Tapentadol Hcl | 31 | $44K |
Prescribing Profile
69
Unique Drugs
24.0
Anomaly Score
Patient Profile
65
Avg Age
59%
Female
1.51
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About